Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Parallel Group Comparison of Loperamide/Simeticone Caplet, Loperamide/Simeticone Chewable Tablet (IMODIUM® PLUS) and a Probiotic (Saccharomyces Boulardii) in the Treatment of Acute Diarrhea in Adults

NCT00807326 is registered in ClinicalTrials.gov with McNeil AB as lead sponsor.

NCT NCT00807326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00807326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Parallel Group Comparison of Loperamide/Simeticone Caplet, Loperamide/Simeticone Chewable Tablet (IMODIUM® PLUS) and a Probiotic (Saccharomyces Boulardii) in the Treatment of Acute Diarrhea in Adults
Lead sponsor
McNeil AB
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2008
Completion date
November 30, 2009
Enrollment
415 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

diarrhea